Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 – IRBT

Faruqi & Faruqi Reminds iRobot Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 5, 2025 – IRBT GlobeNewswire September 07, 2025 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in iRobot To Contact Him Directly To Discuss Their Options If you […]

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

(HKSE:1877.HK),(Shenzhen:688180.SS), SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that company's product, recombinant humanized anti-IL-17A monoclonal antibody (code: JS005) has achieved positive results in a multi-center, randomized, double-blind, parallel,

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR

(NASDAQ:SMLR), NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) — WHY: New York, N.Y., September 7, 2025. Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints GlobeNewswire September 07, 2025 SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – SMLR GlobeNewswire September 07, 2025 NEW YORK, Sept. 07, 2025 (GLOBE NEWSWIRE) — WHY: New York, N.Y., September 7, 2025. Rosen Law Firm, a global investor rights law firm, announces

ROSEN, THE FIRST FILING FIRM, Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm – SMLR

NEW YORK CITY, NY / ACCESS Newswire / September 7, 2025 / WHY: New York, N.Y., September 7, 2025. Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ:SMLR) between March 10, 2021 and April 15, 2025,

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Compass Minerals International Inc. Securities – CMP

The Rosen Law Firm,P.A. announces that the United States District Court for the District of Kansas has approved the following announcement of a proposed class action settlement that would benefit purchasers of Compass Minerals International Inc. securities (NYSE: CMP): UNITED STATES DISTRICT COURT DISTRICT OF KANSAS JOHN VALENTINE and PAUL O'RENICK, individually and on behalf

CNC LAWSUIT ALERT: Levi & Korsinsky Notifies Centene Corporation Investors – Lead Plaintiff Deadline September 8, 2025

NEW YORK, NY / ACCESS Newswire / September 7, 2025 / If you suffered a loss on your Centene Corporation (NYSE:CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=165734&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Lost Money on RxSight, Inc. (RXST)? Contact Levi & Korsinsky Before September 22, 2025 to Join Class Action

NEW YORK, NY / ACCESS Newswire / September 7, 2025 / If you suffered a loss on your RxSight, Inc. (NASDAQ:RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=165735&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Class Action Filed Against Lineage, Inc. (LINE) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / September 7, 2025 / If you suffered a loss on your Lineage, Inc. (NASDAQ:LINE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lineage-inc-lawsuit-submission-form?prid=165733&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Scroll to Top